Article Published 3 Apr 2025 里程碑式判决:经营者集中行政诉讼"第一案"代理有感 China Antitrust/Competition Law AB AnJie Broad Law Firm
Article Published 2 Apr 2025 Safeguards Of Dapagliflozin's Half Billion USD Sales In China: AstraZeneca China Intellectual Property R Rouse
Article Published 28 Feb 2025 China Newsletter | Q4 2024/Issue No. 62 China International Law GT Greenberg Traurig, LLP
Article Published 6 Feb 2025 China Unveils New Anti-Monopoly Guidelines For The Pharmaceutical Sector China Antitrust/Competition Law JD Jones Day
Article Published 29 Jan 2025 China Life Sciences: 2024 Year In Review China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 28 Jan 2025 China Tightens The Reins: Anti-Corruption Compliance Expectations For Companies In The Healthcare Sector China Criminal Law RG Ropes & Gray LLP
Article Published 23 Jan 2025 Chinese Regulators Publish Final Anti-Corruption Guidelines For The Healthcare Industry China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 9 Jan 2025 China Announces Major Policy Incentives For Life Sciences Companies China Food, Drugs, Healthcare, Life Sciences RG Ropes & Gray LLP
Article Published 10 Dec 2024 China's New Draft Administrative Measures For Management Of Medical Representatives China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 5 Dec 2024 The New Draft Administrative Measures For Management Of Medical Representatives China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 28 Nov 2024 中国在医疗和生物技术领域的外资新政策:推动创新发展与加强专利保护 China Food, Drugs, Healthcare, Life Sciences L Lusheng Law Firm
Article Published 27 Nov 2024 Relaxation Of Long-Standing Restrictions On Foreign Investment In The Healthcare Sector In China China Food, Drugs, Healthcare, Life Sciences MW McDermott Will & Emery
Article Published 5 Nov 2024 Landmark Whistleblower Program For China's Healthcare Sector China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 4 Nov 2024 Landmark Whistleblower Program For China's Healthcare Sector: Proposed Maximum Reward Of 1 Million RMB China Food, Drugs, Healthcare, Life Sciences AP Arnold & Porter
Article Published 30 Oct 2024 干细胞与基因治疗领域扩大开放新政及CAR-T地方监管新规初探 China Food, Drugs, Healthcare, Life Sciences AB AnJie Broad Law Firm
Article Published 28 Oct 2024 China's NMPA Announces A Pilot Plan To Allow Non-End-To-End Manufacturing Of Biologics China Food, Drugs, Healthcare, Life Sciences RG Ropes & Gray LLP
Article Published 16 Oct 2024 医疗健康数据的法律保护与合规应用 China Food, Drugs, Healthcare, Life Sciences AB AnJie Broad Law Firm
Article Published 14 Oct 2024 China's New Policies On Foreign Investment In Healthcare And Biotechnology: Catalyzing Innovation And Strengthening Patent Protection China Intellectual Property L Lusheng Law Firm
Article Published 23 Sep 2024 药品反垄断风险"划重点":解读征求意见稿,洞悉未来合规要点 China Antitrust/Competition Law AB AnJie Broad Law Firm